Please check your internet connection and try again.
# Walethmade bromide
## Overview
"Walethmade bromide" is not a recognized generic or brand name in clinical pharmacy literature or FDA databases. It is possible this is a typographical error for **Aclidinium bromide**, **Glycopyrronium bromide**, or another synthetic anticholinergic compound. **Do not administer or prescribe based on this name.**
## Primary Indications
(If intended as an anticholinergic): Maintenance treatment of Chronic Obstructive Pulmonary Disease (COPD) or treatment of excessive drooling (sialorrhea) or hyperhidrosis, depending on the specific agent.
## Adult Dosing
If referring to a generic long-acting muscarinic antagonist (LAMA) such as Aclidinium: 400 mcg inhaled twice daily. Without a confirmed chemical identity, **no safe dose can be provided.**
## Pediatric Dosing
No established dosing for "Walethmade bromide." Pediatric dosing for anticholinergics is highly weight-based and specific to the indication (e.g., glycopyrrolate for sialorrhea: 0.02 mg/kg orally three times daily).
## Dose Adjustments
Renal and hepatic impairment adjustments are standard for bromide-containing anticholinergics; however, these must be verified against the specific pharmacological agent intended.
## Contraindications
Hypersensitivity to the drug or its components. Generally contraindicated in patients with narrow-angle glaucoma, urinary retention, or severe uncontrolled gastrointestinal obstructive conditions.
## Adverse Effects
Common anticholinergic effects include: xerostomia (dry mouth), constipation, urinary retention, blurred vision, tachycardia, and headache.
## Key Drug Interactions
Additive effects observed with other anticholinergics (e.g., antihistamines, tricyclic antidepressants, antipsychotics).
## Monitoring
Monitor for signs of urinary retention, worsening of glaucoma symptoms, paradoxical bronchospasm, and efficacy regarding primary indication.
## Clinical Pearls
* **Identification Error:** There is no pharmaceutical agent known as "Walethmade bromide." Verify the spelling, brand name, or manufacturer information provided on the medication packaging.
* **Look-alike/Sound-alike:** Ensure the medication is not being confused with glycopyrronium (Robinul) or umeclidinium.
* **Consultation:** Contact a licensed pharmacist or use a reliable drug database (e.g., Lexicomp or Micromedex) to identify the correct medication name before proceeding.
***
**Educational Disclaimer:** This information is provided for educational purposes only. The drug name provided is not recognized; do not attempt to dose or administer any medication based on this request. Consult your local formulary, current prescribing information (package insert), or a licensed healthcare professional to verify the correct drug identity and dosing.
